Company Develops a New Approach to Nerve Repair

A new company, Neurotex Ltd, has been established to develop novel silk-based materials that have the potential to provide a new generation of nerve repair materials and treatments.

Neurotex Ltd is a joint venture company, bringing together the expertise of Professor John Priestley, Head of Neuroscience at Queen Mary’s School of Medicine and Dentistry, and the unique silk-based materials technology developed by Dr David Knight, and Dr Nick Skaer of Oxford Biomaterials Ltd. Dr Richard Skipper has been appointed Chief Executive Officer of the new company.

Neurotex Ltd is developing a range of patented devices for the repair of damaged nerves using a modified wild silk developed by Oxford Biomaterials, called Spidrex®.

Spidrex has biological and mechanical properties that make it a highly attractive candidate for nerve repair devices. Initial studies have shown Spidrex to be highly supportive of directed nerve growth with low immunotoxicity. Professor John Priestley, Scientific Founder of Neurotex expects that the research will lead to treatment for peripheral nerve injury, and may eventually lead to treatments for repairing damaged spinal cords – however, he cautions that spinal cord damage is far more complex and a much longer term goal.

Professor John Prestley, Scientific Founder of Neurotex said; “For us it’s an ambitious but realistic goal to repair the peripheral nervous system. If you damage a peripheral nerve, so long as it has a support to follow, the nerve should regrow and hopefully the nerve injury will repair itself. If you damage the spinal cord, however, there are lots of things that will try and prevent the regrowth taking place, such as natural inhibitory components. To repair a damaged spinal cord, we will need different types of tubes and will have to combine other approaches such as stem cells, growth factors or other additives. So it’s a much longer term goal, but the rewards are potentially much greater.” The Kinetique Biomedical Seed Fund has invested £250,000 to develop devices for use in peripheral nerve injury repair.

Source: Queen Mary, University of London

Related stories:

Scientists identify cells for spinal-cord repair
A researcher at MIT's Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Study identifies cells for spinal-cord repair
(PhysOrg.com) -- A researcher at MIT’s Picower Institute for Learning and Memory has pinpointed stem cells within the spinal cord that, if persuaded to differentiate into more healing cells and fewer scarring cells following an injury, may lead to a new, non-surgical treatment for debilitating spinal-cord injuries.
Engineer develops detergent to promote peripheral nerve healing
A detergent solution developed at The University of Texas at Austin that treats donor nerve grafts to circumvent an immune rejection response has been used to create acellular nerve grafts now used successfully in hospitals around the country. Research also shows early promise of the detergent solution having possible applications in spinal cord repair.
Enabling nerve regeneration means evicting the cleanup crew
Macrophages are the immune cells that engulf and destroy the debris of damaged tissue to enable the healing process to begin. Their presence at the scene of damage is critical, but once their task is complete, it is just as critical that macrophages exit rapidly, ending the inflammatory process and making way for regrowth. In fact, the continued presence of macrophages could damage tissue, compromising repair.
Scientists Create Uncanny Cell Replicas for Treatment, Research
Call them genuine fakes. Brown University biomedical engineer Diane Hoffman-Kim and her research team have made plastic replicas of real cells through a novel two-part molding process. The copies looked so authentic, Hoffman-Kim couldn't tell if they were real or rubber at first.
Neurons grown from embryonic stem cells restore function in paralyzed rats
For the first time, researchers have enticed transplants of embryonic stem cell-derived motor neurons in the spinal cord to connect with muscles and partially restore function in paralyzed animals. The study suggests that similar techniques may be useful for treating such disorders as spinal cord injury, transverse myelitis, amyotrophic lateral sclerosis (ALS), and spinal muscular atrophy. The study was funded in part by the NIH's National Institute of Neurological Disorders and Stroke (NINDS).
Statins have unexpected effect on pool of powerful brain cells
Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University of Rochester Medical Center have found. The new findings shed light on a long-debated potential role for statins in the area of dementia.
Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.

News discussion:

Medicine & Health news